Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

James Falko to Male

This is a "connection" page, showing publications James Falko has written about Male.

 
Connection Strength
 
 
 
0.090
 
  1. Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab. 1997 Oct; 82(10):3421-4.
    View in: PubMed
    Score: 0.006
  2. Glueck CJ, Streicher P, Wang P, Sprecher D, Falko JM. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition. 1996 Mar; 12(3):202-5.
    View in: PubMed
    Score: 0.005
  3. Snow R, Ruane J, LaLonde M, Shaffer L, Kim B, Graffagnino C, Falko J, Spencer K, Caulin-Glaser T. Randomized trial assessing the impact of a musculoskeletal intervention for pain before participating in a weight management program. J Cardiopulm Rehabil Prev. 2010 May-Jun; 30(3):173-80.
    View in: PubMed
    Score: 0.003
  4. La Londe MA, Graffagnino CL, Falko JM, Snow RJ, Spencer K, Caulin-Glaser T. Effect of a weight management program on the determinants and prevalence of metabolic syndrome. Obesity (Silver Spring). 2008 Mar; 16(3):637-42.
    View in: PubMed
    Score: 0.003
  5. Falko JM, Parr JH, Simpson RN, Wynn V. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med. 1987 Oct; 83(4):641-7.
    View in: PubMed
    Score: 0.003
  6. Meis SB, Snow R, Lalonde M, Falko J, Caulin-Glaser T. A systematic approach to improve lipids in coronary artery disease patients participating in a cardiac rehabilitation program. J Cardiopulm Rehabil. 2006 Nov-Dec; 26(6):355-60; quiz 361-2.
    View in: PubMed
    Score: 0.003
  7. Osei K, Holland G, Falko JM. Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med. 1986 Oct; 146(10):1973-7.
    View in: PubMed
    Score: 0.003
  8. Osei K, Falko JM. Chronic hyponatremia associated with diabetic amyotrophy. Arch Intern Med. 1986 Mar; 146(3):534-6.
    View in: PubMed
    Score: 0.002
  9. Graffagnino CL, Falko JM, La Londe M, Schaumburg J, Hyek MF, Shaffer LE, Snow R, Caulin-Glaser T. Effect of a community-based weight management program on weight loss and cardiovascular disease risk factors. Obesity (Silver Spring). 2006 Feb; 14(2):280-8.
    View in: PubMed
    Score: 0.002
  10. Hindman L, Falko JM, LaLonde M, Snow R, Caulin-Glaser T. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation. Am Heart J. 2005 Nov; 150(5):1046-51.
    View in: PubMed
    Score: 0.002
  11. Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R. Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil. 2005 Nov-Dec; 25(6):332-6; quiz 337-8.
    View in: PubMed
    Score: 0.002
  12. Falko JM, Osei K. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med. 1985 Sep 20; 79(3B):92-101.
    View in: PubMed
    Score: 0.002
  13. Snow R, LaLonde M, Hindman L, Falko J, Caulin-Glaser T. Independent effect of cardiac rehabilitation on lipids in coronary artery disease. J Cardiopulm Rehabil. 2005 Sep-Oct; 25(5):257-61; quiz 262-3.
    View in: PubMed
    Score: 0.002
  14. Osei K, Falko JM. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Am J Med Sci. 1985 Apr; 289(4):148-53.
    View in: PubMed
    Score: 0.002
  15. Rudy DR, Falko JM. Osteoporosis in primary care. Ohio State Med J. 1985 Mar; 81(3):208-12.
    View in: PubMed
    Score: 0.002
  16. Osei K, Falko JM. Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J. 1984 Dec; 80(12):864-9.
    View in: PubMed
    Score: 0.002
  17. Osei K, O'Dorisio TM, Falko JM. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med. 1984 Dec; 77(6):1002-9.
    View in: PubMed
    Score: 0.002
  18. Patel ST, Newman HA, Yates AJ, Thibert P, Falko JM. Serum lipids and lipoprotein composition in spontaneously diabetic BB Wistar rats. J Lipid Res. 1984 Oct; 25(10):1072-83.
    View in: PubMed
    Score: 0.002
  19. Bossetti BM, Kocher LM, Moranz JF, Falko JM. The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care. 1984 Jul-Aug; 7(4):309-12.
    View in: PubMed
    Score: 0.002
  20. Falko JM, Maeder MC, Conway C, Mazzaferri EL, Skillman TG. Primary hyperparathyroidism: analysis of 220 patients with special emphasis on familial hypocalciuric hypercalcemia. Heart Lung. 1984 Mar; 13(2):124-31.
    View in: PubMed
    Score: 0.002
  21. Falko JM, Reynolds JC, O'Dorisio TM, Bossetti B, Cataland S. The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose. Diabetes Care. 1982 Jul-Aug; 5(4):379-85.
    View in: PubMed
    Score: 0.002
  22. Hawley PC, Falko JM. "Pseudo" renal failure after isopropyl alcohol intoxication. South Med J. 1982 May; 75(5):630-1.
    View in: PubMed
    Score: 0.002
  23. Falko JM, O'Dorisio TM, Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 01; 247(1):37-9.
    View in: PubMed
    Score: 0.002
  24. Stoney CM, West SG, Hughes JW, Lentino LM, Finney ML, Falko J, Bausserman L. Acute psychological stress reduces plasma triglyceride clearance. Psychophysiology. 2002 Jan; 39(1):80-5.
    View in: PubMed
    Score: 0.002
  25. Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Clin Endocrinol (Oxf). 1980 Dec; 13(6):587-93.
    View in: PubMed
    Score: 0.002
  26. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism. 1980 Jul; 29(7):654-61.
    View in: PubMed
    Score: 0.002
  27. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Weidman SW, Steelman R. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab. 1980 Mar; 50(3):521-8.
    View in: PubMed
    Score: 0.002
  28. Falko JM, Schonfeld G, Witztum JL, Kolar J, Weidman SW. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism. 1979 Nov; 28(11):1171-7.
    View in: PubMed
    Score: 0.002
  29. Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med. 1979 Nov; 91(5):750-1.
    View in: PubMed
    Score: 0.002
  30. Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med. 1979 Feb; 66(2):303-10.
    View in: PubMed
    Score: 0.002
  31. Sundaram V, Hanna AN, Lubow GP, Koneru L, Falko JM, Sharma HM. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci. 1997 Nov; 314(5):303-10.
    View in: PubMed
    Score: 0.001
  32. Thomas FB, Sinar D, Caldwell JH, Mekhjian HS, Falko JM. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology. 1977 Aug; 73(2):221-5.
    View in: PubMed
    Score: 0.001
  33. Falko JM. Hazards in antihypertension therapy. Ann Intern Med. 1977 Jan; 86(1):111-2.
    View in: PubMed
    Score: 0.001
  34. Falko JM, Guy JT, Smith RE, Mazzaferri EL. Primary hyperparathyroidism and anemia. Arch Intern Med. 1976 Aug; 136(8):887-9.
    View in: PubMed
    Score: 0.001
  35. Falko JM, Cohen JR. Letter: Erythrocytosis and hypothyroidism. Ann Intern Med. 1976 Apr; 84(4):446-7.
    View in: PubMed
    Score: 0.001
  36. Jhiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM, Mazzaferri EL. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid. 1996 Apr; 6(2):115-21.
    View in: PubMed
    Score: 0.001
  37. Falko JM, Bush CA, Tzagournis M, Thomas FB. Case report. Congestive heart failure complicating the hungry bone syndrome. Am J Med Sci. 1976 Jan-Feb; 271(1):85-9.
    View in: PubMed
    Score: 0.001
  38. Falko JM, Thomas FB. Letter: Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med. 1975 Dec; 83(6):832-3.
    View in: PubMed
    Score: 0.001
  39. Falko JM, Crockett SE, Cataland S, Mazzaferri EL. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab. 1975 Aug; 41(2):260-5.
    View in: PubMed
    Score: 0.001
  40. Osei K, Falko J, Bossetti BM, Holland GC. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med. 1987 Aug; 83(2):249-55.
    View in: PubMed
    Score: 0.001
  41. Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab. 1986 Feb; 62(2):325-30.
    View in: PubMed
    Score: 0.001
  42. Osei K, Falko JM, Fields PG, Bossetti B, O'Dorisio TM. The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia. 1986 Feb; 29(2):100-5.
    View in: PubMed
    Score: 0.001
  43. Abdel-Nabi H, Hinkle GH, Falko JM, Kelly D, Olsen JO, Martin EW. Iodine-131 labeled anti-CEA antibodies uptake by H?rthle cell carcinoma. Clin Nucl Med. 1985 Oct; 10(10):713-5.
    View in: PubMed
    Score: 0.001
  44. Osei K, Falko JM, O'Dorisio TM, Adam DR. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care. 1985 Sep-Oct; 8(5):436-9.
    View in: PubMed
    Score: 0.001
  45. Osei K, Falko JM, O'Dorisio TM, Adam DR, Cataland S. Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients. Diabetes Care. 1984 Sep-Oct; 7(5):442-6.
    View in: PubMed
    Score: 0.001
  46. Osei K, Falko JM, O'Dorisio TM, Adam DR. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care. 1984 Sep-Oct; 7(5):471-5.
    View in: PubMed
    Score: 0.001
  47. Levin P, Falko JM, O'Dorisio TM, Cataland S. Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabetics. Am J Med Sci. 1983 Nov-Dec; 286(3):11-7.
    View in: PubMed
    Score: 0.001
  48. Osei K, Falko JM, Pacht E, Wall R, Goldberg RF. Primary adrenal insufficiency manifesting as malignant lymphoma. Arch Intern Med. 1983 Sep; 143(9):1791-2.
    View in: PubMed
    Score: 0.001
  49. O'Dorisio TM, Falko JM, Cataland S, Almoney RW, George JM, Mazzaferri EL, Reynolds JC. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma. J Clin Endocrinol Metab. 1982 Apr; 54(4):798-802.
    View in: PubMed
    Score: 0.000
  50. Weidman SW, Suarez B, Falko JM, Witztum JL, Kolar J, Raben M, Schonfeld G. Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med. 1979 Apr; 93(4):549-69.
    View in: PubMed
    Score: 0.000
  51. Crockett SE, Cataland S, Falko JM, Mazzaferri EL. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab. 1976 Jun; 42(6):1098-103.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)